| P50 | author | Marcus Conrad | Q56517307 |
| | W. Wurst | Q67390467 |
| | Stéphanie G. Moreno | Q73757461 |
| | Georg W Bornkamm | Q94069890 |
| P2093 | author name string | Kenneth R Chien | |
| | Antonis K Hatzopoulos | |
| | Fred Sinowatz | |
| | Wolfgang Schmahl | |
| | Manuela Schneider | |
| | Markus Brielmeier | |
| | Ursula Just | |
| | Heike Beck | |
| | Ana Banjac | |
| | Cemile Jakupoglu | |
| | Stefanie Lippl | |
| P2860 | cites work | Thioredoxin reductase | Q24531944 |
| | Characterization of mammalian selenoproteomes. | Q27863319 |
| | Cloning, sequencing and functional expression of a novel human thioredoxin reductase | Q28115611 |
| | Human thioredoxin reductase from HeLa cells: selective alkylation of selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin | Q28115980 |
| | Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress | Q28142513 |
| | Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression | Q28191015 |
| | Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice | Q28204189 |
| | DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1 | Q28204282 |
| | Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders | Q28272795 |
| | Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits | Q28505173 |
| | TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome | Q28512803 |
| | Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations | Q28581387 |
| | Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis | Q28591886 |
| | Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems | Q28593944 |
| | A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells | Q29614542 |
| | Physiological functions of thioredoxin and thioredoxin reductase | Q29615600 |
| | Reactive oxygen species, antioxidants, and the mammalian thioredoxin system | Q29619367 |
| | Recombination signal sequence-binding protein Jkappa alters mesodermal cell fate decisions by suppressing cardiomyogenesis | Q30477732 |
| | Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha -/- mice. | Q34051459 |
| | Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis | Q34086331 |
| | Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy | Q34274405 |
| | Mouse embryonic hematopoiesis | Q34289044 |
| | Cloning and sequencing of a human thioredoxin reductase | Q34297828 |
| | The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice | Q34463545 |
| | Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity | Q35076291 |
| | Detection of apoptosis using in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon? | Q35546856 |
| | Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy | Q36417773 |
| | Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing | Q40845256 |
| | Redox-dependent trafficking of 2,3,4,5, 6-pentafluorodihydrotetramethylrosamine, a novel fluorogenic indicator of cellular oxidative activity | Q40869115 |
| | Dynamics and efficiency in vivo of UGA-directed selenocysteine insertion at the ribosome | Q42672346 |
| | E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination | Q42814364 |
| | Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein | Q43664631 |
| | Involvements of mitochondrial thioredoxin reductase (TrxR2) in cell proliferation | Q44410254 |
| | Optimized vector for conditional gene targeting in mouse embryonic stem cells | Q44482475 |
| | cDNA cloning, expression and chromosomal localization of the mouse mitochondrial thioredoxin reductase gene(1). | Q47925664 |
| | Genomic organization and identification of a novel alternative splicing variant of mouse mitochondrial thioredoxin reductase (TrxR2) gene. | Q48292369 |
| | Efficient FLP recombination in mouse ES cells and oocytes | Q48875650 |
| | Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes | Q60687218 |
| | Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat | Q73399760 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| | mitochondrion | Q39572 |
| | hemopoiesis | Q919283 |
| | Thioredoxin reductase 2 | Q21992229 |
| P304 | page(s) | 9414-9423 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function | |
| P478 | volume | 24 | |